schizophrenia

Age-dependent association of cannabis use with risk of psychotic disorder

Scientific article

22 May 2024

Abstract Background Epidemiologic research suggests that youth cannabis use is associated with psychotic disorders. However, current evidence is based heavily on 20th-century data when cannabis was substantially less potent than today...

Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Fifteenth Session)

ISSUP Webinar

22 November 2022

ISSUP Nigeria would like to invite you to their next Bi-Monthly Webinar in the Knowledge Update Series. This Webinar will centre on 'Substance Use Disorders (SUDs) in Schizophrenia: Current Approach to Management'.

Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Fifteenth Session)

22 November 2022

Abuja

Nigeria

Psychotic Disorders Hospitalisations Associated with Cannabis Abuse or Dependence

Scientific article

5 December 2019

Delta 9‐tetrahydrocannabinol - a psychoactive compound found in cannabis - activates parts of the brain responsible for cognition, perception, anxiety, fear, memory and reward. There are continuous debates about the link between cannabis...

Perceptions about Mental Illness among General Practitioners

Scientific article

13 April 2019

Abstract Background General practitioners (GPs) play an important role in the physical care of patients with severe mental illness, so our aim was to analyse the relationships between GPs’ sociodemographic status and worked-related...

Hazardous Alcohol Use among Patients with Schizophrenia and Depression

Scientific article

22 September 2017

Harmful alcohol use is known to increase the risk of alcohol dependence as well as physical conditions such as hypertension, cardiovascular disease, and cirrhosis. Alcohol use disorder (AUD) is a common co-occurring disorder in people with...

Cannabis Use and Risk of Schizophrenia: A Mendelian Randomization Study

Scientific article

24 January 2017

Abstract Cannabis use is observationally associated with an increased risk of schizophrenia, but whether the relationship is causal is not known. Using a genetic approach, we took 10 independent genetic variants previously identified to...

The Links Between Substance Use and Gambling in Schizophrenia

Scientific article

16 February 2018

Highlights High rates of both problem and pathological gambling and substance use disorders have been reported in schizophrenia The research shows that problem and pathological gambling and substance use is linked with increased impulsivity...

Comorbid Opioid Use is Undertreated among Forensic Patients with Schizophrenia

Scientific article

6 November 2018

Abstract Background Substance use disorders are associated with poorer clinical outcomes in patients with schizophrenia. There is no specific treatment for amphetamine or cannabis use disorder, but methadone and buprenorphine are used as...

The Cannabinoid Receptor 1 Associates with NMDA Receptors to Produce Glutamatergic Hypofunction: Implications in Psychosis and Schizophrenia

Scientific article

2 January 2014

The endocannabinoid system is widespread throughout the central nervous system and its type 1 receptor (CB1) plays a crucial role in preventing the neurotoxicity caused by activation of glutamate N-methyl-D-aspartate receptors (NMDARs)...